Good day and thank you for standing by. Welcome to the GEA Group AG Q1 2022 conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question- and- answer session. To ask a question during the session, you will need to press star one on your telephone. Please be advised that today's conference is being recorded. If you require any further assistance, please press star zero. I would now like to hand the conference over to your speaker today, Rebecca Weigl. Please go ahead.
Good afternoon, ladies and gentlemen, and thank you very much for joining us today for our Q1 earnings conference call. With me on the call are our CEO, Stefan Klebert, and our CFO, Marcus Ketter. Stefan will begin today's call with the highlights of the Q1 2022 results. Marcus will then cover the business and financial review, followed by Stefan's outlook for 2022. Afterwards, we open up the call for the Q&A session. As always, I would like to start by drawing your attention to the cautionary language that is included in our safe harbor statement, as in the material that we have distributed today. With that, I hand it over to you, Stefan.
Yeah, thank you, Rebecca, and good afternoon, everybody. It's my pleasure to welcome you to our conference call today. I hope you and your families are still doing well despite the still uncertain environment with the war raging in Eastern Europe and high inflation. Let me start with a quick review of the first quarter of 2022. We had a great start into the year, especially when looking at order intake. Here, we grew organically by more than 20% year-over-year. With EUR 1.54 billion, this marks a new record figure for a single quarter. Also, sales grew significantly compared to last year's Q1. Organic sales grew by 6.6%, well in line with our guidance of more than 5%. This growth rate was achieved despite some supply chain shortages, but let me cover this topic in a minute.
The sales growth translated also into a better EBITDA margin. We reached 12.3%, up from 11.4% last year, or EUR 138 million, despite some inflationary headwind on the supply side, which we had to digest. Finally, return on capital employed, we reached 29.3% on a last four quarter basis, an improvement of almost 10 percentage points year-over-year. In total, a great quarter, however, not without challenges. Let me discuss the achievements and challenges of Q1 on the next slide. Starting with the achievements first, followed by the challenges. The order intake of EUR 1.54 billion is the highest level for a single quarter ever. Sales grew organically by 6.6%, and this was achieved despite some supply chain shortages. EBITDA margin reached 12.3%.
This is also a new record level despite inflationary pressure on the supply side. Capital efficiency also increased further. ROCE stood at 29.3%, a further improvement from Q4, where we reached a record low for our net working capital. I just mentioned the two most challenging topics already, shortages and inflation. Availability of material was more volatile throughout the quarter, and prices have not eased. Clearly, the opposite happened, especially in the last months of the quarter. The war in the Ukraine highly exacerbated the entire situation with the supply chains. Nevertheless, Q1 2022 was once again a quite successful quarter for GEA, despite the challenges I just described. Today is more than ever important to be innovative and to offer our customers solutions to make their processes more efficient, less energy-intensive, and to enable them to reduce their carbon footprint.
Our technology is a solution for our customers to mitigate a part of their input cost inflation. Food producers face significant soft commodity and energy inflation, and food production is a very energy-intensive business. When we developed our Group R&D strategy in 2020, we defined sustainability as one of our four focus areas. This was long before the war started and now proves to be an even more important focus. I would like to explain in two examples how we are improving, helping our customers to increase process efficiency. Both examples were recently developed and are now hitting the market. Let me start with our AddCool solution. AddCool makes our spray dryers more climate friendly. Spray dryers are used to transform fluids into powder, for example, milk into milk powder. This is a highly energy-intensive process.
Our AddCool solution incorporates a heat pump specifically designed for operation in spray dryers. The heat pump, by the way, is of course developed and manufactured by our HRT division. This reduces the need for fossil fuels and allows operators to lower their carbon footprint and energy consumption by up to 50%. A great aspect is that the customer does not necessarily need to replace an entire installed base. Retrofitting is easily possible, which is not only less capital-intensive for customers, but can also be done within a much shorter time than replacing an entire facility with a complete new one. We have just presented this solution at the Anuga FoodTec trade fair in Cologne last week. To put these savings into perspective and make them more tangible, let's take the size of an average spray dryer, which we have sold during the last 20 years.
If we retrofit one of those, the energy savings are about 1,500 kWh per hour of operation. This means, in other words, that the spray dryer saves energy, so much energy per year that we alternatively could supply a small village with about 3,500 households with the savings only. Another great innovation, which is now hitting the market, is our new electric oven generation. Ovens in the business unit bakery were normally using natural gas to generate the desired heat. In general, this is an efficient technology, but everybody is seeking a reduction of natural gas consumption now given the most recent price hikes. Besides the price, it still generates carbon dioxide emissions and handling natural gas always bears at least some risk.
We developed a new generation of ovens, which can either be partly operated with gas and electricity or solely operated with electricity. It sounds very easy, however, a lot of know-how and tests were needed to maintain the quality of the bakery products on the same level as heated with natural gas. In general, this enables our customer to achieve energy savings by up to 20%. Regarding emissions, if the energy source of our customers is entirely renewable, then they are now able to eliminate their CO2 emissions in this process step. These two examples show how we enable our customers to improve their process efficiency and to reduce their costs. With that, I hand over to Marcus, who will take you through the financials of the quarter.
Thank you, Stefan. Also, a warm welcome from my side. Starting with the headline numbers of Q1 2022. The organic increase of order intake was 20.4% year-over-year, with large orders contributing strongly. The three large orders which we booked in Q1 2022 came to a combined EUR 92 million and were all placed in the customer industry dairy processing. In last year's Q1, we only booked one large order in the amount of EUR 34 million in the customer industry food. Sales developed also quite nicely. On an organic basis, sales grew by 6.6% year-over-year, driven by both new machines and service sales. It is worth noting that this was achieved despite some supply chain shortages. The organic sales growth translated into healthy profit growth. EBITDA before structuring expenses improved by 17% to EUR 138 million.
The respective margin increased by 0.9 percentage points to 12.3%. This improvement was achieved despite significant headwind from inflation. Due to the further reduction of net working capital, our ROCE considerably improved. Furthermore, our net liquidity increased by EUR 142 million to EUR 412 million. In addition, own shares were bought for EUR 131 million and are held as treasury shares. All in all, a very successful quarter in a quite challenging environment. Looking a bit deeper into the group performance. Order intake grew to almost EUR 1.54 billion and marks a new record figure. All divisions contributed to that growth, except for Heating & Refrigeration Technologies, declining due to recent divestments.
All order sizes grew year- over- year, with the strongest growth contribution coming from medium-sized orders between EUR 5 million and EUR 50 million. Sales grew organically for the fifth consecutive quarter. Service sales grew by a strong 8.9% organically year- over- year, and new machines grew by 5.4%. The service sales share was 36.2%, one percentage point higher than last year. Gross profit was supported by service and new machines profitability. This, in combination with disproportionally slower growth of operating costs, resulted in an increase of the EBITDA margin by 0.9 percentage points to 12.3% or EUR 138 million. Now let me continue with the figures for Separation & Flow Technologies, which had again a very strong quarter for all key performance indicators.
Order intake grew organically by an outstanding 16.3% year-over-year. Demand was strong across all customer industries, but especially dairy processing stood out. From a sales perspective, in absence of any orders larger than EUR 50 million last and this year, all other order size brackets saw a strong year-over-year growth. Regarding the pipeline, apart from beverage, the situation generally still looks healthy. At dairy, we see good demand. However, as some bigger projects have been awarded in Q1 already, the backlog is already high. Organic sales grew by a strong 14.9% year-over-year, with service growing by 14.8% and new machines growing by 14.9%. Due to the slightly stronger growth in the new machine business compared to service, the service sales share declined slightly by 0.2 percentage points to 45.8%.
Order backlog currently stands at a record level of EUR 572 million and therefore indicates further growth ahead. EBITDA increased significantly from 19 to EUR 81 million and the EBITDA margin improved by 2.7 percentage points to 24.9%. This development was driven by the healthy organic sales growth and better capacity utilization. Gross profit was significantly higher than last year, and operating costs increased just slightly year-over-year. Let's move on to Liquid & Powder Technologies. Order intake increased organically by an outstanding 33.5% year-over-year. This development was driven by two customer industries. First, dairy processing, where we booked all large orders of this quarter totaling EUR 92 million. Second, chemicals, which is the key driver behind the strong growth in the EUR 5 million-EUR 50 million size bracket.
Regarding the pipeline, we do see a continued favorable hotlist for projects for the entire year. While food is a bit muted, new food shows an ongoing dynamic development. In dairy processing and chemicals, there are still some attractive projects in the pipeline despite the already high order intake in Q1. Furthermore, LPT experienced a very high interest at the trade fair, Anuga FoodTec. Sales increased by 8.4% year-over-year on an organic basis. Both service and new machines contributed to this solid figure. Following the high order backlog created during the last two quarters, service grew organically by 9.3% and new machine sales by 8.2% year-over-year. The service sales share rose slightly by 0.1 percentage points to 21.4%.
Going forward, sales should further increase as backlog has now reached another new record level with EUR 1.5 billion. This, however, assumes that the supply chain bottlenecks are not worsening. EBITDA before structural expenses increased by EUR 5 million to EUR 28 million, and the margin improved from 6.8%-7.3%. While operating costs were slightly above prior year's level, gross profit improved due to higher sales volume. Continuing with Food & Healthcare Technologies. Order intake increased organically by 9.7% year-over-year.
Growth was driven by strong demand for medium-sized projects in food-related applications. Going forward, we expect that our food-related applications will continue their positive performance in the short term. Increasing our pharma order intake remains challenging in 2022, but only given the high order intake already in 2021. Organic sales, however, were 5.6% down year-over-year.
While service sales grew organically by 6.4% year-over-year, new machine sales declined organically by 10.2%, which was impacted by supply chain shortages. These shortages especially occurred in electronics and affected sales execution. As a result of the new machine sales decline and the service sales growth, the service sales share strongly increased by 3.7 percentage points to 31.8%. From an order backlog perspective, the situation is very satisfactory. It reached a new record level of EUR 663 million. Due to the weak organic sales development, gross profit declined slightly, leading to a year-over-year reduction of EBITDA by EUR 1 million to EUR 20 million. Nevertheless, we managed to keep the margin stable at 9.6%. Moving to Farm Technologies.
Despite the strong order intake in prior year's Q1, order intake grew strongly by 14.2% organically. Some farmers are likely to have pulled their orders forward, anticipating further price hikes. Growth was generally driven by a strong demand for highly efficient automated milking equipment. However, conventional milking equipment experienced a slowing demand also due to farmers reacting on price increases. The milk price development remains favorable for farmers. However, farmers are also facing inflation for supplies in the form of higher prices for feed and fuel, as well as higher equipment prices. It might be therefore likely that order intake growth will normalize in the short term. Sales increased organically by 9.3% year-over-year. Due to the very strong order intake growth during the last quarters, new machines grew stronger than service sales.
New machine sales grew organically by 10.9% and service sales by still 7.7% year-over-year. Thus, the service sales ratio arithmetically declined by 0.6 percentage points to 50.3%. However, service sales in EUR increased from EUR 67 million to EUR 74 million year-over-year. EBITDA decreased by EUR 3 million, also due to an unexpected rapid rise of input materials in the hygiene segment recently. Accordingly, the margin declined to 6.8% from 10.3%. Finally, let us turn to Heating & Refrigeration Technologies. Reported order intake declined by 3.9% year-over-year due to divestments. The organic order intake figure, however, increased by a strong 14.2% year-over-year. The general environment remains good and is especially driven by demand for heat pumps.
Organic sales increased by 3.9% year-over-year and was driven by new machines growing by 5.6%. Service sales grew organically by 1.4% year-over-year, and its share increased by 1.6 percentage points to 41.9%. The increase of the service sales share is also driven by the divestments mentioned earlier. EBITDA before structural expenses increased by EUR 130 million, and the margin improved from 8.2% to 10.7%. A decline in gross profit driven by the divestments was more than compensated by a reduction in operating expenses. Closing the divisional chapter now with the next slide. The strongest contribution for EBITDA came from Separation & Flow Technologies and Liquid & Powder Technologies. On a reported basis, two divisions had lower sales in the quarter.
Only at Food & Healthcare Technologies, sales declined due to supply bottlenecks, as well as Heating & Refrigeration Technologies, but due to negative M&A effects. Separation & Flow and Liquid & Powder Technologies increased gross profit, but remained flat at Farm Technologies due to the increase in input prices discussed earlier. The shortages at Food & Healthcare Technologies were also a burden for its gross profit development. Gross profit at Heating & Refrigeration declined due to the divestments discussed earlier. Operating costs are well under control. The increases are explained by the higher sales volume and were disproportionately lower than sales growth. In total, EBITDA before restructuring increased to EUR 138 million from EUR 121 million. On the right side of the chart, we deducted the translational FX effect of EUR 3 million.
Excluding this FX effect, as we have defined it in our full year guidance, our EBITDA would have still improved by EUR 14 million to EUR 135 million. Coming now to one of my favorite topics, net working capital. Net working capital declined year-over-year by EUR 84 million to EUR 292 million. This improvement came especially from the division Liquid & Powder Technologies. Also, Food & Healthcare Technologies, as well as Separation & Flow Technologies contributed positively. The most significant year-over-year improvements were achieved at trade payables, which improved by EUR 86 million, at net contract assets, which improved by EUR 80 million, and at trade receivables, which improved by EUR 28 million. Inventories increased year-over-year by EUR 109 million, also driven by the backlog. Furthermore, an increase in work in progress and finished goods were the reasons behind the high inventory level.
Coming now to another important topic, cash generation. Operating cash flow was a negative EUR 40 million, which is below last year's figure of positive EUR 46 million. The decline is explained by higher net working capital in comparison to year-end 2021, as well as EUR 75 million outflow in provision. The latter position contains the outflow for bonus payments for the whole group and also including EUR 11 million for the payment of our pensions. Which was, as you know, a successful year. CapEx-related outflow is EUR 50 million, higher than last year, resulting in EUR 33 million. The increase is mainly due to investments into our new plant in Koszalin, Poland, and high replacement CapEx. As a result, free cash flow is negative at EUR 49 million and below last year's figure of positive EUR 18 million.
However, our free cash flow conversion ratio before restructuring clearly exceeds our targeted conversion ratio of 55%-65% of EBITDA. 82% of EBITDA has been converted into free cash flow on a last four quarters trading basis. Net cash, including lease liabilities, declined from EUR 500 million at the end of the fourth quarter to EUR 412 million. Besides the negative net cash flow of EUR 49 million, the share buyback in the amount of EUR 37 million also reduced our cash position. Let me now talk about our financial headroom. On the left, you'll see our available cash credit lines, as well as the respective utilization and maturity structure as per end of March 2022.
Two variable tranches of borrower's note loans expiring in 2023 in the amount of EUR 28 million, as well as in 2025 in the amount of EUR 22 million, were prematurely redeemed. The reason is the extraordinary good liquidity situation and the interest we are paying for these notes. The EUR 81 million due to this year constitute evergreen credit lines. Continuing now on the right side of the slide, compared to last year's Q1, the financial headroom declined by EUR 300 million. The reason for this decline is one, on the one hand explained by the cancellation of an unused credit line with the EIB, European Investment Bank, of EUR 100 million. On the other hand, a syndicated credit facility of EUR 200 million, which was solely set up due to the uncertainty from the global pandemic.
The syndicated credit line was not prolonged and expired in August 2021. The positive trend of our net liquidity, including lease liabilities, has continued improving by EUR 142 million to EUR 412 million year-over-year. With that, I hand back to Stefan for the outlook.
Thank you very much, Marcus. What does that all mean for our 2022 guidance? Despite all the challenges in the environment, we feel comfortable with our guidance and confirm the guidance. Therefore, we expect organic sales growth by more than 5% year-over-year, and EBITDA before restructuring expense between EUR 630 million and EUR 690 million, and a return on capital employed in the range of 24%-30%. As of now, the risk from direct exposure to Russia and Ukraine appears manageable from today's perspective and does not have an impact on our guidance range. Contrary, the negative effect of the indirect exposure can currently not be reliably assessed. But as I said, everything we see, we are comfortable with the guidance and we confirm the guidance. Finally, this brings me to our roadmap for 2022.
The next important date will be in August with our Q2 numbers. This concludes my presentation, and I hand back to Rebecca for the Q&A session.
Many thanks, Stefan and Marcus, for the presentation of our Q1 results. Dear ladies and gentlemen, we are now happy to take your questions.
Thank you. As a reminder, to ask a question, you will need to press star one on your telephone. To withdraw your question, press the pound hash key. Once again, please press star one if you would like to ask a question. Your first question today comes from the line of Klas Bergelind from Citi. Please go ahead. Your line is open.
Thank you. Hi. Hi, Stefan and Marcus, Klas at Citi. The first one I have is on pricing. Can you help us, Stefan, with how much the organic growth in revenues was pricing this quarter and split between services and equipment? If you could comment on the pricing in the product business and how the pass-through is working currently. We've obviously seen several companies with big backlogs fighting big price cost pressures versus earlier cycle names handling it better. Obviously I'm not asking you to speculate on future cost inflation, but against the current cost inflation, if you could give us a sense of your confidence level. Obviously, you reiterated a guide, but I would like to have a little bit more detail. I'll start there.
Yes. I mean, what we can say and what you also can see that, so far we are managing that very good because you could see that we also increased our margin in the first quarter. Our price increase, which we had in the first quarter in the order intake is about 5%-6%. That also makes us very optimistic that we can cover the cost. Also, other costs which might hit in the next month.
On the revenue line as well, Stefan, if you could help us here from the screen, sort of the difference between orders and revenues on the pricing, if you have it.
Revenue, it should be in the range of 2%-3%.
Okay. Very good. My second one is a follow-up to the EUR 120 million, or follow-up to this cost inflation, the EUR 120 million that you talked about last quarter. I think you said back then that you were half covered for the year on the energy side, more naked, if you like, into the second half. General inputs have also gone up again since we last spoke. I'm curious if you have a new number for that one twenty, whether that is one thirty, one forty, maybe more. Yeah.
Okay. Hi, Klas. This is Marcus. That was a gross figure, because there were also savings also at the purchasing. It's a very fluid situation, so what we're gonna do now is to give you a net figure where we say, "Okay, this is the price increase we see in total coming out of purchasing." That net figure is in a range of EUR 120 million-EUR 140 million. As I said, it's a net figure, not really comparable to gross figure you're just referring to. Then looking at the situation, we also wanna give everyone here a little bit more insight on that so that it's clear what's that we can manage that.
With EUR 120-140 million net price increases coming out of purchasing, that means that's around 2.5%-2.9% of revenue. In other words, we need to increase the revenue by 2.5%-2.9% to neutralize that effect there.
Very clear. It seems obviously, given what's going on on orders and the conversion that that seems possible. My very final one is on the order intake for the second quarter. You had some pre-ordering in farm tech, but quite small impact at group level. It seems if this was only in farm tech and underlying demand seems to be around EUR 1.4 billion extra large orders. I think you mentioned a little bit about some muted momentum in food. You said that the daily backlog is already high. Are we cautioning a little bit on any end market sequential? If you could help us, Stefan, with maybe the actual order number, what you're targeting for the second quarter. Thank you.
Yeah. I would— [crosstalk] Thank you, Klas. I would not say that we are, let's say, cautioning. We see very good project activity still ongoing. I mean, we had—If you remember our numbers, we grew organically by 20% in the first quarter. We grew last year in the full year 15%. We did not have any strong decline in the significant COVID year. For the next quarter, we would expect, I would say, minimum EUR 1.3 billion, but also could be EUR 1.4 billion intake.
Thank you.
You're welcome.
Thank you. Your next question comes from the line of Uma Samlin from Bank of America. Please go ahead. Your line is open.
Hi. Good afternoon, Stefan and Marcus. Thank you for taking my question. My first question is on the overall demand picture. Could you please just give us a bit more color on what's been driving exceptionally strong demand? You know, to what extent do you see the order, the pre-ordering contributing to that? Have you seen any change in sort of sentiment of your customers given that what has happened in Russia and now the lockdown in China? Or do you continue to see very strong momentum in orders?
Perhaps let me take that question. Overall demand is pretty good. The overall, t he picture has not changed for us. Of course what you see is there's a lot of inflation in the value chain, but the overall demand in our end markets has been quite good. Russia-Ukraine affects us. As we said, it's manageable. It affects us, but it's manageable, but didn't have any real effect on the overall picture. The China question is more really for our suppliers, actually, if there's a clogging of ships there in Shanghai, and if that actually adds to the pain in the supply chain, but doesn't really take anything away from the demand in our industries. Especially dairy processing has been very strong in the last quarter.
Okay. Thank you very much. I guess my second question is that, you know, given your order intake remains to be very strong and the disconnect between your order intake growth and sales growth have potentially widened further this quarter. When do you expect sales growth to somewhat catch up toward the level of your order backlog growth? What do you need? I mean, what do we need to see to happen for the sales growth to accelerate in the year? To what extent does it depend on the supply chain challenges?
Yeah, that's a good question. I think we are in the same situation like you can see in almost every industry at the moment. Backlog is increasing and it is not so easy to execute sales simply because of supply chain shortages. It is also not easy to say when will it be fully opened again. We feel at the moment restrictions in the supply chain. We cannot unfortunately process the backlog as soon as we would like to do that. As I said, we are in a good situation with all the other companies. It's very difficult to predict.
I mean, it will definitely remain, I would say, for the rest of the year, that it is that there is still a supply chain shortage and that we will see bottlenecks in supply chains. So far I think we handle it very good. I mean, we could achieve a significant organic growth in the first quarter and we are continuing to manage the situation, yeah.
Thank you very much.
Thank you. Your next question comes from the line of Max Yates from Credit Suisse. Please go ahead. Your line is open.
Thank you very much. Just my first question was around the Separation & Flow margin. That was obviously very strong this quarter, with pretty high incremental margins. I just wanted to understand, could you talk a little bit about kind of what drove that specifically? And then maybe from here at sort of 24.9%, is that sustainable or do we think there was something kind of that may be artificially elevated that this quarter, so we should be a bit more conservative? Some color around that would be helpful. Thank you.
That was, as you said, a very good EBITDA margin. The reason is that we are seeing the effect of a higher revenue there and higher utilization of capacity at SFT and with the operating leverage, then the EBITDA margin considering growth. That's the simple answer to your question. The higher revenue actually accelerates the margin improvement. Can expect this going further. We have very strong order intake at SFT, therefore, we do not see that the revenue would be going down. Quite the opposite. We think the revenue will be further going up.
The only thing which might actually hinder us a bit are supply chain issues, challenges there, where we cannot convert order intake as quickly into revenue or proportionally into revenue as it is. There was also a question actually when will that change, there. Right now we're on upwards trajectory in regards to revenue, and so the good margin should be able that we keep them.
Okay. Just in terms of that supply chain impact, do you have a number in mind of sort of how much that cost you in terms of revenues in the quarter?
No. Actually, we have, as you have seen, we have an increasing revenue, but it's not proportionally increasing through the percentage increase of order intake. That is my point. We expect to see further increasing revenue as we guide it. We feel quite comfortable with the guidance we set for this year, greater than 5%. However, as you have seen, order intake grew by 20.4%, so we are lagging behind the revenue growth there, so.
Sure. That makes sense. Just final one. Within your free cash flow bridge, you have a EUR 75 million outflow for provisions. Could you just talk a little bit, I think you mentioned kind of variable compensation related outflows, but obviously it looks quite large in terms of the cash flow. Could you just sort of clarify exactly what that is?
Yeah. That's pure cash flow, so it's nothing to do with any expense for the last quarter. The expense was taken when we put in the accrual last year. Approximately EUR 65 million of that is the total for bonus payments, which we have done in the first quarter. We utilized the accrual we had there for the cash payment. An additional approximately EUR 11 million is the cash payment for our pensions there. That makes up the number of EUR 75 million.
Understood. Thank you very much.
Thank you. Your next question comes from the line of Akash Gupta from J.P. Morgan. Please go ahead. Your line is open.
Yes. Hi, good afternoon, everybody, and thanks for your time. My first question is also on the demand and not just the near-term demand, but demand picture in the next, let's say, four to six quarters. I mean, if you look at the current situation right now, we have food inflation that is quite unprecedented and might worsen in the coming period. We have weakness in euro that may make you a bit more competitive than your U.S. competitors. But then we also have higher energy cost and then higher energy efficiency focus from your customer side to invest or upgrade. Taking all these puts and takes into account, like, how do you see the demand picture to pan out in the next four quarters?
Like, do you see any sign of a worry on the horizon that we might see some kind of weakness after, let's say, a couple of good quarters? Or do you think that we might see a more sustained demand growth in the next four to six quarters? That's the question number one.
Okay. I would say, I mean, my favorite sentence is always, as long as there are human beings on that earth who need to eat and drink something, our business is in safe harbor. It doesn't matter how much more food will cost, people need to eat, people need to drink, and people need medicine. Therefore, I would say the demand will remain very strong. There are especially two additional factors which we expect will help us to accelerate growth in the medium to long term. This is, first of all, the pressure on energy saving. I gave you two examples in the presentation at the beginning, that we are really focusing in R&D to develop energy-saving devices because production of food is always a very energy-intensive business.
It has to do a lot with fermentation, with pasteurization, and then you have the cold chain as well. Energy saving is a huge topic. We started to focus on that topic already 1.5 year ago, and we expect that we can release a lot of interesting products, and I gave you two examples, to help our customers to save energy, which is important for them because of two reasons. First, to reduce the CO2 footprint independent of what energy costs. The other factor is, of course, the price of the energy. As higher energy cost is, as more our customers will be willing and have a need to invest in modernizations and new devices. The second very interesting thing is the new food topic.
We just had in Cologne the trade show Anuga, where we presented our first mobile test center for new food and that was perceived very well. We have at the moment much more requests from a lot of traditional customers, also a lot of startups, that they wanna work together with us to find out if their processes are working. We even have a bottleneck here that we have too little resources to serve them with that speed the market is questioning. To summarize it, the overall demand as long as the population is growing, people need to eat and drink something. This is a continuous growing demand, and on top of that, we see the thing with the that customers need to save energy and the additional drivers new food.
We are very optimistic that also growth will remain intact in the future.
Thank you for the comprehensive answer. If I may ask a follow-up on working capital. I mean, at 6.1%, your working capital is still significantly below, or not significantly, but somewhat below the guidance corridor that you have set. We are at a time when companies are still building up inventory because of the supply chain disruptions. Maybe if you can comment on how should we see working capital development in the next couple of quarters? Thank you.
Yeah. We left the guidance actually in place for the reasons because there will be, of course, some inventory build-up. We also, that was also seen in the first quarter. But we were able actually to manage that pretty well. It was two percentage points approximately below last year's quarter and just one percentage point above the end of last year. There might be some build-up in work in progress and in inventory. We think that we will still be able to manage that, but we are still careful actually to change the guidance range which we have given there. I don't expect that you will see a major uptick in net working capital.
There's, of course, some upwards pressure in regards to, as I said, inventory is including a work in progress. We are very tightly managing our accounts receivable and now also have programs in place for the accounts payable to extend with our suppliers on their payment terms.
Thank you.
Thank you. Your next question comes from the line of Lars Brorson from Barclays. Please go ahead. Your line is open.
Thank you. Hi. Good afternoon, Stefan and Marcus. Can I start, Marcus, maybe just following up on the price cost equation? I think is an important question for the year. Just clarify exactly what is meant by gross versus the new net. Am I to assume that the earlier gross of 120 versus I think we talked about 150, 200 basis points of pricing, so call it EUR 80 million of pricing was a net 40 that now goes to a net 120-140, and that is following incremental raw material price increases that have come through and also your incremental pricing that you have pushed through. Sorry to be. But just to be absolutely clear, when you talk about needing another 2.5-2.9% of pricing to neutralize, that is incremental to what?
To what you've already priced through on an accumulated basis or what you priced through in Q1? Sorry, I'll start there, please.
Okay. First, what we gave you, just to clarify, was a gross figure, meaning how much do we see the purchasing prices increase and how much do we see still purchasing savings, which is mitigating this effect. We said that's actually a situation that's way too liquid to do it that way, so we're switching the methodology actually now to simply a net figure. What we see is the net price increases coming out of purchasing. There we're on the same page, right? Now I said it's EUR 120 million-EUR 140 million, that net figure, which is coming out of purchasing price increases.
My calculation was that considering our revenue of around EUR 4.8 billion, that means to mitigate this effect for the whole year, we would have to have, for the whole year, a price increase of 2.5%-2.9% on the basis prior to the increase of EUR 120 million-EUR 140 million. That was my point. Did I make myself clear?
I think you did. You need to neutralize pricing for the full year, 2.5%-2.9%. I think you said you priced up orders 5%-6% in Q1, revenue 2%-3%. Maybe the question therefore is what confidence do you have in achieving price cost neutrality for the full year, or if not for the full year, for the second half of the year?
That's the price increase we see, as I said, for the whole year. There's also an effect between the quarters or between the first and the second half of the year. We have done already price increases last year. All in all, we feel actually quite comfortable to mitigate this effect, especially looking at the 2.5%-2.9%. We did price increases which were higher last year already.
Can I ask secondly just to the raw material equation, and just at a high level, what will be the updated gross raw materials impact? Maybe I can go back and calculate that, but I'm curious as to how to think about the impact around pricing in on your sourced components and raw material. You typically don't work with a lot of hedging, but you obviously with alloys, particularly nickel alloys, have some quite meaningful exposures there. Maybe you can also just clarify what, if any, of your key metals and alloys are hedged. If none of it is, how to think about the impact, particularly from nickel, for you this year, please.
Okay. We don't hedge because we don't buy nickel directly. We have a lot of pre-products where we have stainless steel and of course the nickel in there. But that's why we don't hedge, because we are not sourcing simply stainless steel and a bit of carbon steel. It's all in the pre-products we are purchasing from our suppliers. Therefore it's very hard to say how much the volume of that is in tons, and then do the calculation how much nickel we would have to hedge there. It's all in the pre-products. What we see, we do a thorough analysis here constantly of what we see the supplier prices increasing.
Considering the raw material price increases, which go into the calculation of our suppliers, but that's not only the raw material there. They have their labor, they have the EP, they have their profit, et cetera. We see that the price increase, and coming back now to the number, is EUR 120 million-EUR 140 million coming out of purchasing, including all the alloy and steel and stainless steel price increases, there.
Finally, if I can just ask divisionally to Farm Technologies on the point of price cost. I know you don't give a sort of bridge, divisionally, but can you help us with how much specifically was price cost impact to margins in Q1 for Farm Technologies? Just to clarify, the majority of that raw material pressures coming through from Farm Technologies is in cleaning chemicals, so in the aftermarket. I guess you're still to see perhaps more meaningful price cost pressure on the machine side. Just to clarify, if you can, what sort of raw mat pressures you were facing in the quarter on margins in FT, please. Thank you.
Well, we faced around EUR 6 million in EBITDA, which we lost in the first quarter due to price cost there. In that case, there were two raw materials which increased incredibly in a very short period of time, and we couldn't actually increase the prices fast enough in that sense. We did this after the fact, but we lost around EUR 6 million in the first quarter of earnings in comparison to where we should have been with the margin. The increase was so quick, unbelievable, and plus it happened in North America actually there. It gives you some color on that.
Thank you.
Right now, we seem to be back on track.
That's helpful. Thank you.
Thank you. Ladies and gentlemen, if you would like to ask a question, please press star and one on your telephone. Your next question comes from the line of Sebastian Kuenne from RBC. Please go ahead. Your line is open.
Yeah. Hi, gentlemen. I have a question on the discontinued operations which gave you a gain of EUR 10.4 million, and it's a recurrent position on businesses that you exited sometimes, like, 15 years ago. I was wondering whether this stays in the books, whether we should see ongoing bookings of EUR 10 million, EUR 15 million gains, and that's one question. The other question is that cash effective at some point? It doesn't seem to be cash effective, one, but do you then generate that cash? How should we treat this going forward? How should we plan this going forward? I have questions on the supply chain afterwards. Thank you.
Let's do that first, Sebastian. Quick answer to the cash effect is zero. There's no cash effect, and I'll explain to you why. There's an interest change. It's an interest change effect, which we have in discontinued operations. The increase in interest rates then leading to a decrease in accruals in the discontinued operations, as you mentioned here. That was from the sale of the Lurgi and Lentjes companies decades ago. It's simply a change in the accruals by higher interest. That's the answer.
For how many years should we expect that to continue? Because it's quite distorting.
I mean, if the interest rates don't move, then the accruals don't move. If the interest rate is going up and down, then the accrual is also going up and down. That's it.
Oh, it's only depending on.
With rising interest rates, we're gonna see a release of accruals. With declining interest rates, we would see more. Right now, the future looks like rising interest rates, so there might be some decline in accruals still ahead of us. As I said, it's non-cash. We're gonna highlight that, and you can simply take this out from EPS.
Yeah. Good. On the supply issues, you mentioned it's difficult to quantify how much your revenue would have been had you not had these supply issues. Maybe you can tell us a bit about equipment on transit. You know, we have these delayed shipping or logistics times or longer logistics times. Can you quantify the equipment that is, you know, en route somewhere longer, more than usually? Is that EUR 10 million, EUR 20 million, EUR 30 million? Can you give us a number there maybe?
You mean our equipment or the equipment we are buying? The answer to both of these questions.
Your equipment that you are selling, but you can't, you know, you can't account for as revenues because it's still en route.
Okay.
It's still in some port.
Yeah
in, you know.
No, that is actually not an issue. I mean, not a material issue. Let's put it this way. That's why we don't have the revenue. The material issue is really getting parts, chip controllers. We have now some WIP or more WIP at our companies because we cannot ship it at all. It's not that they are en route and it takes longer. That has not been, let's say, at least a material issue in recognizing the revenue. The problem really is getting all the parts to be able to ship it, to ship systems at all.
If there would have been not this chip shortages with controller unit shortages as an example, the revenue increase would be much higher. That's the situation right now.
Understood. Two more brief questions. Russia is now completely out, and is there any more write-down risk?
No
Your production, is it at capacity at the moment, with all the inefficiencies that you have? Are you at capacity now?
What happened for us in Russia is our business has been diminished by around 55%. We have not written off all the assets because we are still doing business there. However, it's a very focused business along the lines of the sanctions, of course. Even if without sanctions, we would do no business in oil and gas. We are really just focusing on the food, beverage and pharmaceutical there. No material write-down has been done in the first quarter. But we are monitoring the situation and it all depends actually on the future outlook if there needs to be a write-down or not.
From for the last quarter, that has not been the case. As we said, as everyone says, it's a very liquid situation, so let's see how that's gonna evolve further.
Mm-hmm. On the capacity utilization of the group overall, with all the inefficiencies, are you running at capacity? Would you say all the people are, you know, fully back in the factories? Do you need to expand?
Yeah
Workforce? What's the situation?
Yeah, I mean, we also have always a lot of flexibility in all our factories with temp workers. That is of course what we are using. As you can see that we are growing and that we are also generating more sales than last year in the first quarter. That also means that our productions are quite full. People are busy, and that will also continue because, I mean, we have the backlog. Sometimes we are missing specific parts and then it takes a little bit longer to deliver the final machine to our customers. We are fully loaded and there is no risk of under absorption. Mm-hmm. Thank you very much.
Thank you. Your next question comes from the line of Himaya Bundya from UBS. Please go ahead. Your line is open.
Thank you. Good afternoon, Stefan, Marcus Ketter and Rebecca Weigl. Himaya Bundya from UBS. Just a few questions from me. Your overall margin execution was very good in Q1. Do you see this continuing for the remainder of the year, and do you think that you could achieve at least a 13.5% EBITDA margin for this year?
Yeah. I mean, as you say, we started quite good in the first quarter. We showed that we are managing the situation very well. We have enough order backlog, so of course, we are also depending on external factors like availability of all the supply chain parts. We are very optimistic to walk our talk and to continue in increasing our margin further.
I know the question was asked previously, but on Farm Technologies, the margin was quite below expectations. I appreciate you've just given an answer on that. Given that, you know, the pricing actions that you've already taken on hygiene price, do you expect the sequential improvement to be seen in Q2 already, or could it be a bit longer?
Yeah. We expect that we are back on track here with that issue in Q2.
Final question from me. What are your free cash flow expectations for the full year after some weakness in Q1?
Well, the cash conversion ratio, we are still committed to the 55%-65% range.
Well, thank you.
Thank you. We will now take our final question, and the question comes from the line of Akash Gupta from J.P. Morgan. Please go ahead. Your line is open.
Yes. Hi. Thanks for taking up my follow-up. I have it on the supply chain topic. Have you given any number, like how much of your bill of materials or your purchasing is intercontinental, like coming from Asia or U.S. to Europe or from one continent to other, and how much of your supply chain or your purchase is local for local? Any number on that would be great. Thank you.
I mean, the majority of our suppliers are local. That's also, I mean, having in mind that the majority of our productions are in Europe. Sourcing in Europe plays an important role for all the projects and things we execute in Asia or US. We also have local suppliers. 85% minimum is sourced locally. Thank you.
Thank you. I will now hand the call back for closing remarks.
Okay. Thank you everybody for listening to our Q1 call, and thanks for the very good and interesting questions. Let me summarize it. We had a good start into a very challenging year 2022. I think we showed that we are increasing our margins further. We grew by more than 20% of order intake. We are above our guidance in sales growth, and we also see significant improvement in EBITDA margin. That's all in line with our full year guidance, and we also are happy and proud to confirm the full year guidance despite all the challenges we discussed and are around of us. We are very optimistic that we can balance all the headwinds by price management and deliver what we promised also this year at the end of the year. Thank you very much.
Stay healthy, and let's all hope that the war stops soon.
Thank you. This concludes today's conference call. Thank you for participating. You may now disconnect.